Patrick O`Connor
Angel Investor
Patrick O`Connor is a startup investor. Patrick O’Connor has a long career in the field of oncology drug discovery and development. His contributions include over 100 publications and patents, and over 20 compounds brought successfully into development, including the recently approved anticancer drugs Xalkori (Crizotinib, PF-234,1066) and Inlyta (Axitinib, AG-13736), discovered while atPfizer, where Patrick served as the Global Research Therapeutic Area Head for Oncology. Several additional investigative agents that Patrick helped bring into early clinical development are currently undergoing trials in cancer patients, including PF-136,7338 (PARP, PII, Pfizer/Clovis), PF-344,6962 (Anti-ALK mAb, PI, Pfizer), RDEA119 (MEK, Phase II, Ardea/Bayer), and PEGPH20 (HA, Phase I, Halozyme). Patrick is a Co-Founder of Selexagen Therapeutics that licensed the B-RAF Adaptation Inhibitor Program to Ruga Corporation where he now oversees Oncology activities. He also serves as one of the Senior Editors at the journal Cancer Research and is a member of the Scientific Advisory Boards of Molecular Response and Deciphera Pharmaceuticals. Prior to joining the pharmaceutical industry, Patrick spent 10 years at the National Cancer Institute in Bethesda, Maryland investigating the molecular underpinnings of chemosensitivity. He has a Ph.D. in Experimental Oncology Therapeutics from Manchester University, England.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Patrick O`Connor?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
